aloxistatin

ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate

SRVFFFJZQVENJC-IHRRRGAJSA-N CHEBI:101381 9 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

9 Reactome pathways

Metabolite details

Identifier: SRVFFFJZQVENJC-IHRRRGAJSA-N
InChI Key: SRVFFFJZQVENJC-IHRRRGAJSA-N
IUPAC name: ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate
Preferred name: aloxistatin
INN name: aloxistatinum
Synonym: Loxistatin
ChEBI: CHEBI:101381

Reactome pathways

R-HSA-1643685 - Disease
R-HSA-5663205 - Infectious disease
R-HSA-9678108 - SARS-CoV-1 Infection
R-HSA-9678110 - Attachment and Entry
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9694516 - SARS-CoV-2 Infection
R-HSA-9694614 - Attachment and Entry
R-HSA-9772572 - Early SARS-CoV-2 Infection Events
R-HSA-9824446 - Viral Infection Pathways

Observed in studies

Observed in differential profiles